查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1854707

工業微生物市場按產品類型、應用、最終用戶、技術和微生物類型分類－2025-2032年全球預測

Industrial Microbiology Market by Product Type, Application, End User, Technology, Organism Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，工業微生物市場規模將達到 350.3 億美元，年複合成長率為 8.36%。

關鍵市場統計數據
基準年 2024 184.1億美元
預計年份：2025年 199.6億美元
預測年份 2032 350.3億美元
複合年成長率 (%) 8.36%

具有前瞻性的方向，闡述了工業微生物學如何整合技術創新、營運擴展和監管指導，從而實現跨行業的商業性化應用。

工業微生物學正迅速從一門專業科學學科發展成為永續製造、治療創新和循環經濟舉措的策略引擎。該領域正與先進的生物製程工程、計算菌株設計和新興原料供應鏈相互融合，從而改變企業對生產風險、產品上市時間和成本結構的思考方式。投資者和技術領袖不僅關注生物系統的能力，也關注支撐這些能力的生態系統：可擴展的生物反應器、可重複的下游工作流程以及促進工業應用的監管途徑。

本導言將讀者置於科學與商業化的交會點。它確立了核心領域：包括高價值分子和生物基大宗材料在內的產品類別；涵蓋農業到環境修復等應用領域的廣泛應用；以及將運作或採購這些技術的機構使用者。此外，它還強調了建立健全的分析流程以及研發、監管和營運團隊之間跨職能協作的必要性。透過闡明目前影響決策的因素，本部分旨在幫助領導者解讀詳細的分析結果，並優先考慮投資，從而在合理的時間範圍內實現技術成熟和市場應用。

全面審視再形成工業微生物學並重新定義競爭和營運模式的重大技術、監管、金融和永續性驅動型變革。

工業微生物學領域正因技術、政策和市場預期三者交匯融合而發生變革，機會與風險也隨之改變。合成生物學和自動化菌株工程的發展縮短了研發週期，降低了早期失敗率；生物反應器控制和下游製程的改進提高了產量穩定性，並降低了規模化生產的變異性。同時，永續性發展的迫切需求和企業淨零排放承諾正在再形成對生物基原料和循環生產方式的需求，促使各組織重新評估其材料採購和生命週期指標。

法律規範也在不斷發展，監管機構正在明確基因改造生物、環境釋放和產品標籤等方面的要求。這種監管勢頭可能會加速或阻礙商業化進程，這取決於其與合規路徑的契合度以及公眾的接受程度。投資者對平台技術和垂直整合營運模式的興趣日益濃厚，這些模式將菌株開發與管理式生產相結合。最後，模組化、分散式生產系統的日益普及催生了新的經營模式，例如合約開發和生產、分散式微型工廠以及按產量付費的服務模式。

本報告對美國近期貿易行動至2025年期間將如何影響工業微生物學相關人員的生物製程投入、設備採購和戰略採購選擇進行了綜合分析。

美國近期推出的關稅措施和貿易政策調整將持續到2025年，這些措施增加了生技藥品原料和設備供應鏈的成本和物流複​​雜性，並引發連鎖反應，產業領導者必須對此有所預見。針對進口實驗室設備、特殊化學品和某些發酵耗材的關稅，如果國內沒有其他供應商，可能會增加到岸投入成本並延誤資本計劃。這些變化將影響供應商合格認定，以及企業在多大程度上優先考慮在地採購、回流生產和策略性庫存緩衝以保障關鍵營運。

關稅導致的供應鏈重組不僅會直接影響成本，還會改變籌資策略和夥伴關係模式。依賴海外專用生物反應器組件或專有試劑的公司將面臨更長的前置作業時間和潛在的單一來源風險，因此多供應商評估和供應商彈性計畫的重要性日益凸顯。另一方面，隨著企業加快國內替代方案的認證，一些國內供應商和整合商的需求可能會增加。企業還必須考慮間接影響，例如關稅合規行政負擔加重、貨運動態變化以及可能影響長期資本預算的政策波動。為了有效應對，企業需要將關稅敏感性情境納入其採購、風險管理和採購藍圖，同時持續關注影響全球貿易流動的政策發展和外交動態。

一種綜合性的、以細分為主導的觀點，將產品類型、應用領域、最終用戶畫像、技術模式和生物體類型聯繫起來，從而確定開發路徑和商業契合度的優先順序。

從細分市場層面了解情況，可以發現技術發展在哪些方面滿足了商業性需求，以及在哪些方面受到營運限制，阻礙了技術的應用。以產品為中心的細分涵蓋胺基酸、抗生素、生質燃料、生質塑膠、酵素和維生素。酵素尤其值得關注，因為其在動物飼料、清潔劑和食品加工等目標市場中有著不同的下游商業化路徑，而每個市場都有不同的配方和監管要求。應用細分涵蓋農業、生質燃料、環境修復、食品飲料和製藥。在製藥領域，藥物發現和配方的動態變化會影響研發進度和監管複雜性，進而導致不同的投資前景。

終端用戶細分區分了農業公司、環境保護機構、食品製造商、製藥公司和研究機構，這決定了採購速度、風險接受度以及對長期夥伴關係的期望。技術細分著重於生物反應器、細胞培養、下游加工和發酵，其中發酵進一步細分為固體發酵和液態發酵，二者在穩健性、資本密集度和原料靈活性方面存在差異。生物類型分為藻類、細菌、真菌和酵母，細菌進一步細分為革蘭氏陰性菌和革蘭氏陽性菌。整合這些細分層級可以突出哪些協同投資（例如，將液態發酵技術與用於特定酶產品的革蘭氏陽性菌生產宿主相結合）能夠加速商業化，以及哪些終端用戶需求與技術成熟度之間的不匹配會造成摩擦，需要製定有針對性的開發和夥伴關係策略。

透過策略性區域評估，識別美洲、歐洲、中東和非洲以及亞太地區的創新叢集、製造業優勢和政策環境，為全球擴張計畫提供資訊。

地理動態持續影響技術能力、監管清晰度和資本匯聚的地點，從而形成創新和製造能力中心。在美洲，成熟的生物叢集支撐著從研發到製造的一體化價值鏈，並受益於深厚的創業投資網路和成熟的合約研發生產機構（CDMO）生態系統。歐洲、中東和非洲則呈現出異質性格局：歐洲部分地區擁有完善的監管環境，而其他地區則對新興製造業的需求日益成長，永續性發展政策推動了對生質塑膠和可再生生物基解決方案的需求。

亞太地區的特點是產能快速擴張、公共和私人部門積極投資生物產業工業，以及上游原料生產商和下游加工商之間高度整合的供應鏈。區域專業化程度至關重要，有些地區優先發展藥品和生技藥品，而有些地區則專注於大宗生質燃料和工業酶，這影響企業如何夥伴關係、技術轉移和監管協調。跨境因素，包括貿易協定、智慧財產權保護和區域標準的協調統一，持續影響企業研發中心和製造地的選址。因此，決策者必須評估區域優勢，而不能孤立地看待，而應將其納入多司法管轄區的策略考量，以最佳化客戶接近性、供應鏈穩健性和監管協調性。

檢驗決定競爭優勢的企業策略和經營能力，包括平台所有權、垂直整合、夥伴關係和人力資本實力。

公司層面的動態變化揭示了其競爭地位的形成，而這種競爭地位源自於技術平台、製造能力和商業通路的獨特組合。一些公司專注於平台菌株的工程設計和許可，建立深厚的智慧財產權和模組化技術體系，從而實現快速客製化。另一些公司則透過將菌株開發與專有的發酵製程和下游純化相結合，進行垂直整合，縮短獲利路徑。還有一部分公司作為靈活的服務提供者和契約製造，為沒有內部設施的新興開發商提供規模化生產和生產能力。在這些模式下取得成功的公司展現出嚴謹的計劃執行能力、完善的品質體系，以及將實驗室可重複性與穩定的工業生產結合的能力。

與原料供應商、法規顧問和承購客戶建立跨產業夥伴關係的公司可以降低早期商業營運風險並加速產品推廣。與設備供應商和自動化廠商建立策略聯盟可以進一步提升營運績效。此外，對數位化過程控制和分析的投資能夠區分那些能夠穩定擴展規模、但又難以應對波動性的企業。最後，人力資本，例如經驗豐富的發酵科學家、法規事務專家和營運經理，仍然是關鍵的差異化因素，能夠幫助公司執行複雜的計劃並快速應對技術或法規方面的挑戰。

為領導者提供以行動為導向的建議，以加強供應鏈、提升製造靈活性、整合監管前瞻性並協調商業性夥伴關係，從而實現快速規模化發展。

產業領導者必須優先考慮兼顧創新和營運韌性的實際行動。首先，加強供應商多元化和資格確認通訊協定，減少關鍵設備、試劑和耗材的單一來源採購。其次，投資模組化、靈活的生產設施，以實現產品快速切換，並相容於液態和固體發酵方法，從而最佳化不同產品類型和終端市場的材料利用率和製程經濟性。

企業還需要在研發專案早期階段就納入監管訊息，以使菌株工程和製程設計與可預測的合規路徑保持一致，並縮短藥品、食品應用和環境排放核准的時間。研發、營運和商業部門之間的跨職能整合能夠加強優先排序，並確保技術里程碑反映買方檢驗的規範。領導者應尋求策略夥伴關係關係，以確保承購和原料協議，並探索與本地製造合作夥伴的共同投資安排，以降低資本密集度並加快市場進入。最後，對員工進行生物製程自動化、品質系統和數據分析的培訓，將使企業能夠維持可重複的生產和持續改進。

一份透明的調查方法概述，其中描述了主要訪談、次要技術分析、細分市場分類和情境測試。

本分析的調查方法結合了定性和定量方法，以確保技術可信度和商業性相關性。主要研究包括對行業高管、技術領導者、採購專家和監管顧問進行結構化訪談，以獲取關於營運限制、策略重點和新興機會的第一手觀點。次要研究則檢驗了同行評審文獻、專利概況、監管指導文件和公司披露資訊，以驗證技術聲明並追蹤不同生物物種和工藝模式下的技術成熟度路徑。

分析方法包括交叉細分映射，以確定產品類型與特定技術棧和最終用戶需求的匹配程度；情境分析，以檢驗採購和營運假設對政策和貿易發展的敏感度；以及能力比較評估，以衡量公司層面的優勢。在整個過程中，研究結果透過多方資訊來源進行三角驗證，以減少偏差，並突出共識觀點和關鍵分歧。這種調查方法既能得出可靠的結論，又能根據具體的組織環境和策略問題進行細緻入微的解讀。

簡明扼要的總結強調，工業微生物學的創新需要整合營運、監管和商業能力，才能實現持續的市場影響。

工業微生物學正日趨成熟，成為一個策略性領域，技術創新必須與務實的營運設計和監管前瞻性相結合，才能實現商業性目標。那些將平台級菌株工程與靈活的生產策略和多元化的採購管道結合的企業，將更有能力應對政策變化和供應鏈中斷。基於細分市場的策略將有助於找到針對特定產品類型和終端市場的最佳發展路徑。

負責人應抓住機遇，透過增加對流程分析、人才培育和合作夥伴生態系統的投資，將自身的技術能力轉化為具有韌性的經營模式。這樣做有助於降低執行風險，在以夥伴關係永續性的市場中獲得先發優勢，並使其能夠靈活應對不斷變化的法規和貿易環境。商業性成功將取決於開發、製造、採購和市場推廣等各環節的整合能力。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 推出人工智慧驅動的生物製程最佳化平台，以提高微生物發酵的產量
  • 擴大精準發酵技術規模，實現乳製品和肉蛋白的永續生產
  • 利用 CRISPR-Cas9 基因編輯技術加速特種化學品的生物合成
  • 開發一種基於微生物群落的生物反應器，用於高效處理工業污水
  • 利用基因最佳化的PHA累積微生物擴大生物基塑膠的生產規模
  • 將即時微生物生物感測器整合到生物製造過程中以進行品管

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的工業微生物市場

  • 胺基酸
  • 抗生素
  • 生質燃料
  • 生質塑膠
  • 酵素
    • 動物飼料
    • 清潔劑
    • 食品加工
  • 維他命

9. 按應用分類的工業微生物市場

  • 農業
  • 生質燃料
  • 環境
  • 食品/飲料
  • 製藥
    • 藥物發現
    • 開處方藥

10. 按最終用戶分類的工業微生物市場

  • 農業企業
  • 環境機構
  • 食品製造商
  • 製藥公司
  • 研究所

11. 按技術分類的工業微生物市場

  • 生物反應器
  • 細胞培養
  • 下游加工
  • 發酵
    • 固體發酵
    • 深層發酵

12. 依微生物類型分類的工業微生物市場

  • 藻類
  • 細菌
    • 革蘭氏陰性菌
    • 革蘭氏陽性菌
  • 真菌
  • 酵母菌

13. 各地區工業微生物市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 工業微生物市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國工業微生物市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Novozymes A/S
    • Koninklijke DSM NV
    • DuPont de Nemours, Inc.
    • BASF SE
    • Evonik Industries AG
    • Chr. Hansen Holding A/S
    • Ajinomoto Co., Inc.
    • Kerry Group plc
    • Lonza Group AG
    • Archer Daniels Midland Company
Product Code: MRR-957C47F92627

The Industrial Microbiology Market is projected to grow by USD 35.03 billion at a CAGR of 8.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 18.41 billion
Estimated Year [2025] USD 19.96 billion
Forecast Year [2032] USD 35.03 billion
CAGR (%) 8.36%

A forward-looking orientation describing how industrial microbiology integrates technical innovation, operational scaling, and regulatory navigation to enable commercial adoption across industries

Industrial microbiology is rapidly evolving from a specialized scientific discipline into a strategic engine for sustainable manufacturing, therapeutic innovation, and circular economy initiatives. The field now intersects advanced bioprocess engineering, computational strain design, and emergent feedstock supply chains in ways that change how companies conceive of production risk, time to market, and cost structures. Investors and technology leaders are focusing not only on the capabilities of biological systems but on the ecosystem that enables them: scalable bioreactors, reproducible downstream workflows, and regulatory pathways that permit industrial adoption.

This introduction situates the reader at the nexus of science and commercialization. It establishes the core domains-product classes that include high-value molecules and bulk bio-based materials, application areas from agriculture to environmental remediation, and the institutional users who operate or procure these technologies. It emphasizes the imperative for robust analytical pipelines and cross-functional collaboration between R&D, regulatory, and operations teams. By clarifying the drivers that currently shape decision-making, this section prepares leaders to interpret detailed analyses and to prioritize investments that deliver technical maturity and market relevance within realistic timelines.

A synthesis of the key technological, regulatory, financial, and sustainability-driven changes reshaping industrial microbiology and redefining competitive and operational models

The landscape of industrial microbiology is being transformed by converging shifts in technology, policy, and market expectations that alter both opportunity and execution risk. Advances in synthetic biology and automated strain engineering have shortened development cycles and reduced failure rates at early stages, while improvements in bioreactor control and downstream processing have increased yield consistency and reduced variability at scale. At the same time, sustainability imperatives and corporate net-zero commitments are reshaping demand toward bio-based inputs and circular manufacturing approaches, pushing organizations to re-evaluate feedstock sourcing and life-cycle metrics.

Regulatory frameworks are also evolving, with authorities clarifying requirements for genetically modified organisms, environmental releases, and product labeling. This regulatory momentum accelerates or constrains commercialization depending on alignment with compliance pathways and with public acceptance. Financing patterns are shifting as well: investors demonstrate growing interest in platform technologies and vertically integrated plays that combine strain development with manufacturing control. Finally, the increased availability of modular and distributed production systems is enabling new business models, including contract development and manufacturing, decentralized microfactories, and pay-per-output service arrangements, which collectively alter how companies scale and compete.

An integrated analysis of how recent United States trade measures through 2025 affect bioprocess inputs, equipment procurement, and strategic sourcing choices for industrial microbiology stakeholders

Recent tariff actions and trade policy adjustments in the United States through 2025 have introduced additional layers of cost and logistical complexity across biologics inputs and equipment supply chains, with ripple effects that industry leaders must anticipate. Tariffs that target imported laboratory equipment, specialty chemicals, or certain fermentation consumables elevate landed input costs and can delay capital projects when alternative suppliers are not available domestically. These shifts influence supplier qualification decisions and the degree to which organizations prioritize local sourcing, onshoring, or strategic inventory buffering to protect critical operations.

Beyond immediate cost implications, tariff-driven supply chain realignments change procurement strategies and partnership models. Entities reliant on specialized foreign bioreactor components or proprietary reagents face longer lead times and potential single-source risks, which increases the value of multi-sourcing assessments and vendor resiliency planning. Conversely, some domestic suppliers and integrators may see expanded demand as firms accelerate qualification of local alternatives. Firms must also weigh the indirect impacts: increased administrative burden for customs compliance, shifting freight dynamics, and the potential for policy volatility that complicates long-term capital budgeting. To respond effectively, organizations should integrate tariff sensitivity scenarios into sourcing, risk management, and procurement roadmaps while continuing to monitor policy developments and diplomatic shifts that affect global trade flows.

A comprehensive segmentation-driven perspective linking product categories, application domains, end-user profiles, technology modalities, and organism types to prioritize development pathways and commercial fit

Segment-level understanding reveals where technical development aligns with commercial demand and where operational constraints constrain adoption. Product-focused segmentation spans amino acids, antibiotics, biofuels, bioplastics, enzymes, and vitamins; within this frame, enzymes warrant special attention because their downstream commercialization paths differ depending on target markets such as animal feed, detergents, and food processing, each with distinct formulation and regulatory requirements. Application segmentation covers agriculture, biofuels, environmental remediation, food and beverage, and pharmaceuticals, and within pharmaceuticals the dynamics of drug discovery versus drug formulation influence timelines and regulatory complexity, creating divergent investment profiles.

End-user segmentation differentiates agriculture firms, environmental agencies, food manufacturers, pharmaceutical companies, and research institutes, which in turn determine procurement cadence, risk tolerance, and long-term partnership expectations. Technology segmentation emphasizes bioreactors, cell culture, downstream processing, and fermentation, where fermentation further divides into solid state and submerged approaches that vary by robustness, capital intensity, and feedstock flexibility. Organism type segmentation distinguishes algae, bacteria, fungi, and yeast, and the bacterial category subdivides into Gram-negative and Gram-positive strains, which carry different genetic toolkits and containment considerations. Synthesizing these segmentation layers clarifies where synergistic investments-such as pairing submerged fermentation expertise with Gram-positive production hosts for specific enzyme outputs-deliver accelerated commercialization, and where mismatches between end-user needs and technological maturity create friction that demands targeted development or partnership strategies.

A strategic regional appraisal identifying innovation clusters, manufacturing strengths, and policy environments across the Americas, Europe Middle East & Africa, and Asia-Pacific to inform global deployment plans

Geographic dynamics continue to influence where technological capability, regulatory clarity, and capital converge to create hubs of innovation and manufacturing capacity. In the Americas, established industrial biotech clusters support integrated development-to-manufacturing value chains, strengthened by deep venture capital networks and mature CDMO ecosystems; this region often leads in translational platforms that bridge discovery and scale-up. Europe, Middle East & Africa exhibits a heterogeneous landscape where regulatory sophistication in parts of Europe coexists with emerging manufacturing ambitions elsewhere, and where sustainability-oriented policy initiatives drive demand for bioplastics and renewable bio-based solutions.

Asia-Pacific is characterized by rapid capacity expansion, aggressive public and private investment in bioindustrial parks, and strong supply-chain integration with upstream feedstock producers and downstream processors. Regional specialization matters: certain countries within each region prioritize pharmaceuticals and biologics, while others focus on bulk biofuels or enzymes for industrial use, influencing how companies approach partnerships, technology transfer, and regulatory alignment. Cross-border considerations, such as trade agreements, intellectual property protection, and regional standards harmonization, continue to shape where companies establish R&D centers and manufacturing footprints. Decision-makers must therefore assess regional advantages not only in isolation but as part of a multi-jurisdictional strategy that optimizes proximity to customers, robustness of supply chains, and regulatory alignment.

An examination of corporate strategies and operational capabilities that determine competitive advantage including platform ownership, vertical integration, partnerships, and human capital strengths

Company-level dynamics reveal competitive positioning that stems from unique combinations of technological platforms, manufacturing capability, and commercial channels. Some firms concentrate on platform strain engineering and licensing, building deep IP estates and modular technology suites designed for rapid customization, while others vertically integrate to combine strain development with proprietary fermentation processes and downstream purification that shorten paths to revenue. A third cohort operates as flexible service providers and contract manufacturers, offering scale-up and production capacity to emerging developers who lack in-house facilities. Across these models, successful companies demonstrate disciplined project execution, robust quality systems, and the ability to translate laboratory reproducibility into consistent industrial output.

Collaborative behavior also differentiates leaders: those that form cross-sector partnerships with feedstock suppliers, regulatory consultants, and offtake customers can de-risk early commercial runs and accelerate adoption. Strategic alliances with equipment suppliers and automation vendors further strengthen operational performance. Additionally, investments in digital process control and analytics separate organizations that can reliably scale from those that struggle with variability. Finally, human capital-experienced fermentation scientists, regulatory affairs professionals, and operations managers-remains a critical differentiator, enabling firms to execute complex projects and to respond rapidly to technical or regulatory challenges.

Action-oriented recommendations for leaders to fortify supply chains, modernize manufacturing flexibility, integrate regulatory foresight, and align commercial partnerships for rapid scale-up

Industry leaders must prioritize pragmatic actions that balance innovation with operational resilience. First, strengthen supplier diversification and qualification protocols to reduce single-source exposure for critical equipment, reagents, and consumables; this reduces vulnerability to trade disruptions and supports predictable scale-up timelines. Next, invest in modular and flexible manufacturing assets that enable rapid product changeover and that accommodate both submerged and solid state fermentation modalities to optimize feedstock use and process economics across product types and end markets.

Firms should also embed regulatory intelligence early in development programs, aligning strain engineering and process design with foreseeable compliance pathways to reduce time-to-approval friction for pharmaceuticals, food applications, and environmental releases. Cross-functional integration between R&D, operations, and commercial functions will enhance prioritization and ensure that technical milestones translate into buyer-validated specifications. Leaders should pursue strategic partnerships that secure offtake or feedstock contracts, and they should explore co-investment arrangements with local manufacturing partners to mitigate capital intensity and to accelerate market entry. Finally, cultivating workforce skills in bioprocess automation, quality systems, and data analytics will ensure that organizations can sustain reproducible manufacturing and continuous improvement.

A transparent methodological overview describing primary interviews, secondary technical analysis, segmentation mapping, and scenario testing used to produce defensible and actionable conclusions

The research methodology underpinning this analysis combined qualitative and quantitative approaches designed to ensure technical credibility and commercial relevance. Primary research included structured interviews with industry executives, technical leaders, procurement specialists, and regulatory advisors to capture firsthand perspectives on operational constraints, strategic priorities, and emergent opportunities. Secondary research synthesized peer-reviewed literature, patent landscapes, regulatory guidance documents, and company disclosures to validate technical claims and to trace technology maturation paths across organism types and process modalities.

Analytical techniques included cross-segmentation mapping to identify where product types align with specific technology stacks and end-user requirements, scenario analysis to test the sensitivity of sourcing and operational assumptions to policy and trade developments, and comparative capability assessments to benchmark firm-level strengths. Throughout the process, findings were triangulated across multiple sources to reduce bias and to highlight both consensus views and material disagreements. This methodology supports robust conclusions while allowing for nuanced interpretation tailored to specific organizational contexts and strategic questions.

A concise synthesis reinforcing that technical innovation in industrial microbiology requires integrated operational, regulatory, and commercial capabilities to realize durable market impact

The conclusion synthesizes the report's central insights: industrial microbiology is maturing into a strategic domain where technical innovation must be matched by pragmatic operational design and regulatory foresight to achieve commercial outcomes. Organizations that pair platform-level strain engineering with flexible manufacturing strategies and diversified sourcing are best positioned to navigate policy shifts and supply-chain disruptions. Regional differences will continue to influence where firms prioritize capital deployment, while segmentation-informed strategies illuminate the most viable paths for specific product types and end markets.

Leaders should treat the current moment as an opportunity to translate technological capability into resilient business models by accelerating investments in process analytics, workforce development, and partnership ecosystems. By doing so, they can reduce execution risk, capture early adopter advantages in sustainability-oriented markets, and position their organizations to respond nimbly to evolving regulatory and trade conditions. The cumulative message is clear: technical excellence alone is necessary but insufficient; commercial success depends on integrated capability across development, manufacturing, procurement, and market engagement.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI-driven bioprocess optimization platforms to enhance microbial fermentation yields
  • 5.2. Expansion of precision fermentation techniques for sustainable dairy and meat protein production
  • 5.3. Implementation of CRISPR-Cas9 strain engineering to accelerate specialty chemical biosynthesis
  • 5.4. Development of microbial consortia-based bioreactors for efficient industrial wastewater treatment
  • 5.5. Scale-up of bio-based plastic production using genetically optimized PHA-accumulating microorganisms
  • 5.6. Integration of real-time microbial biosensors into biomanufacturing processes for quality control

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Industrial Microbiology Market, by Product Type

  • 8.1. Amino Acids
  • 8.2. Antibiotics
  • 8.3. Biofuels
  • 8.4. Bioplastics
  • 8.5. Enzymes
    • 8.5.1. Animal Feed
    • 8.5.2. Detergents
    • 8.5.3. Food Processing
  • 8.6. Vitamins

9. Industrial Microbiology Market, by Application

  • 9.1. Agriculture
  • 9.2. Biofuels
  • 9.3. Environmental
  • 9.4. Food And Beverage
  • 9.5. Pharmaceuticals
    • 9.5.1. Drug Discovery
    • 9.5.2. Drug Formulation

10. Industrial Microbiology Market, by End User

  • 10.1. Agriculture Firms
  • 10.2. Environmental Agencies
  • 10.3. Food Manufacturers
  • 10.4. Pharmaceutical Companies
  • 10.5. Research Institutes

11. Industrial Microbiology Market, by Technology

  • 11.1. Bioreactor
  • 11.2. Cell Culture
  • 11.3. Downstream Processing
  • 11.4. Fermentation
    • 11.4.1. Solid State Fermentation
    • 11.4.2. Submerged Fermentation

12. Industrial Microbiology Market, by Organism Type

  • 12.1. Algae
  • 12.2. Bacteria
    • 12.2.1. Gram Negative
    • 12.2.2. Gram Positive
  • 12.3. Fungi
  • 12.4. Yeast

13. Industrial Microbiology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Industrial Microbiology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Industrial Microbiology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Novozymes A/S
    • 16.3.2. Koninklijke DSM N.V.
    • 16.3.3. DuPont de Nemours, Inc.
    • 16.3.4. BASF SE
    • 16.3.5. Evonik Industries AG
    • 16.3.6. Chr. Hansen Holding A/S
    • 16.3.7. Ajinomoto Co., Inc.
    • 16.3.8. Kerry Group plc
    • 16.3.9. Lonza Group AG
    • 16.3.10. Archer Daniels Midland Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. INDUSTRIAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. INDUSTRIAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INDUSTRIAL MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE INDUSTRI